Assessment of response to all clinical measures after 54 and 102 weeks of treatment for all 52 patients who participated in the second year study
| Assessment | Baseline | Week 54 | Week 102 | p Value | |
|---|---|---|---|---|---|
| wk 0 v wk 102 | wk 54 v wk 102 | ||||
| Results are shown as mean (SD) unless otherwise stated. | |||||
| Global disease assessment (VAS) | |||||
| Patient (0–10 cm) | 6.9 (1.9) | 2.8 (1.9) | 2.6 (2.0) | <0.0001 | 0.39 |
| Physician (0–10 cm) | 6.3 (1.6) | 2.2 (1.5) | 2.0 (1.4) | <0.0001 | 0.14 |
| BASDAI | 6.4 (1.4) | 2.5 (1.7) | 2.6 (2.0) | <0.0001 | 0.61 |
| BASFI | 5.2 (1.9) | 3.0 (2.2) | 3.0 (2.2) | <0.0001 | 0.88 |
| BASMI | 3.8 (2.0) | 2.4 (2.0) | 2.7 (2.1) | <0.0001 | 0.038 |
| CRP (mg/l), median (range) | 21.5 (0.9–74.0) | 3.9 (0–17.8) | 4.3 (0–42.7) | <0.0001 | 0.51 |
| ESR (mm/1st h), median (range) | 25.0 (3–88) | 8.0 (1–70) | 7.5 (2–70) | <0.0001 | 0.39 |
| SF-36 | |||||
| Physical component | 29.3 (7.0) | 40.6 (10.6) | 40.9 (11.1) | <0.0001 | 0.73 |
| Mental component | 42.3 (12.2) | 50.9 (8.9) | 50.2 (9.5) | <0.0001 | 0.47 |